{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:25:20Z","timestamp":1790076320634,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":2656,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["572516"],"award-info":[{"award-number":["572516"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["634414"],"award-info":[{"award-number":["634414"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical and Health Research Infrastructure"},{"DOI":"10.13039\/501100001170","name":"Cancer Council Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001170","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.exphem.2014.11.009","type":"journal-article","created":{"date-parts":[[2014,12,20]],"date-time":"2014-12-20T03:22:37Z","timestamp":1419045757000},"page":"191-206.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Loss of c-Cbl E3 ubiquitin ligase activity enhances the development of myeloid leukemia in FLT3-ITD mutant mice"],"prefix":"10.1016","volume":"43","author":[{"given":"Samuel J.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine B.F.","family":"Thien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha A.","family":"Dagger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna M.","family":"Duyvestyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S.","family":"Grove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Gary","family":"Gilliland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wallace Y.","family":"Langdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2014.11.009_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood.V100.1.59","article-title":"Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease","volume":"100","author":"Schnittger","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.11.009_bib2","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1182\/blood.V98.6.1752","volume":"98","author":"Kottaridis","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.11.009_bib3","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood-2008-01-132431","article-title":"Segmental uniparental disomy is a commonly acquired genetic event in relapsed acute myeloid leukemia","volume":"112","author":"Raghavan","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.11.009_bib4","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1182\/blood.V96.12.3907","article-title":"Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways","volume":"96","author":"Mizuki","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.11.009_bib5","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/sj.onc.1203354","article-title":"Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines","volume":"19","author":"Hayakawa","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2014.11.009_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2004-07-2942","article-title":"AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations","volume":"106","author":"Choudhary","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.11.009_bib7","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1182\/blood-2008-12-196055","article-title":"FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation","volume":"114","author":"Yoshimoto","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.11.009_bib8","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/leu.2010.114","article-title":"Ubiquitin conjugase UBCH8 targets active FMS-like tyrosine kinase 3 for proteasomal degradation","volume":"24","author":"Buchwald","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.11.009_bib9","doi-asserted-by":"crossref","first-page":"30263","DOI":"10.1074\/jbc.M111.232348","article-title":"c-Cbl and Cbl-b mediate 17-AAG-induced degradation of autophosphorylated Flt3-ITD through the ubiquitin proteasome pathway","volume":"286","author":"Oshikawa","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2014.11.009_bib10","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1182\/blood-2007-01-066076","article-title":"Flt3-dependent transformation by inactivating c-Cbl mutations","volume":"110","author":"Sargin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.11.009_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1042\/BJ20050892","article-title":"c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses","volume":"391","author":"Thien","year":"2005","journal-title":"Biochem J"},{"key":"10.1016\/j.exphem.2014.11.009_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbamcr.2012.10.010","article-title":"Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases","volume":"1833","author":"Mohapatra","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.exphem.2014.11.009_bib13","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1158\/0008-5472.CAN-10-0610","article-title":"Cbl and human myeloid neoplasms: the Cbl oncogene comes of age","volume":"70","author":"Kales","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2014.11.009_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ccr.2010.09.008","article-title":"Myeloid leukemia development in c-Cbl RING finger mutant mice is dependent on FLT3 signaling","volume":"18","author":"Rathinam","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.11.009_bib15","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1182\/blood-2012-06-436675","article-title":"Flt3 inhibitor AC220 is a potent therapy in a mouse model of myeloproliferative disease driven by enhanced wild-type Flt3 signaling","volume":"120","author":"Taylor","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.11.009_bib16","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1038\/sj.emboj.7600841","article-title":"Loss of c-Cbl RING finger function results in high-intensity signaling and thymic deletion","volume":"24","author":"Thien","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2014.11.009_bib17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ccr.2007.08.031","article-title":"FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia","volume":"12","author":"Lee","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.11.009_bib18","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1182\/blood-2010-06-289207","article-title":"Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD-induced myeloproliferation","volume":"118","author":"Kharazi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.11.009_bib19","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1182\/blood-2011-10-382283","article-title":"Knock-in of a FLT3\/ITD mutation cooperates with a NUP98-HOXD13 fusion to generate acute myeloid leukemia in a mouse model","volume":"119","author":"Greenblatt","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.11.009_bib20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.V100.1.238","article-title":"Bethesda proposal for classification of nonlymphoid hematopoietic neoplasms in mice","volume":"100","author":"Kogan","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.11.009_bib21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.stem.2012.05.027","article-title":"FLT3-ITD knockin impairs hematopoietic stem cell quiescence\/homeostasis, leading to myeloproliferative neoplasm","volume":"11","author":"Chu","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2014.11.009_bib22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ccr.2011.10.012","article-title":"IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development","volume":"20","author":"Reynaud","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2014.11.009_bib23","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1101\/gad.1651408","article-title":"The E3 ubiquitin ligase c-Cbl restricts development and functions of hematopoietic stem cells","volume":"22","author":"Rathinam","year":"2008","journal-title":"Genes Dev"},{"key":"10.1016\/j.exphem.2014.11.009_bib24","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1182\/blood-2007-08-109942","article-title":"Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model","volume":"111","author":"Li","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.11.009_bib25","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1128\/MCB.25.9.3690-3703.2005","article-title":"Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases","volume":"25","author":"Schmidt-Arras","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2014.11.009_bib26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2011-12-389932","article-title":"Aberrant STAT5 and PI3K\/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia","volume":"120","author":"Tasian","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.11.009_bib27","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1182\/blood-2006-06-030312","article-title":"FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia","volume":"111","author":"Kim","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.11.009_bib28","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/leu.2012.37","article-title":"Molecular and cellular effects of oncogene cooperation in a genetically accurate AML mouse model","volume":"26","author":"Reckzeh","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.11.009_bib29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.leu.2404951","article-title":"MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment","volume":"22","author":"Stubbs","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.11.009_bib30","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1038\/leu.2013.77","article-title":"A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice","volume":"27","author":"Mupo","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2014.11.009_bib31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2013.12.016","article-title":"Proto-Oncogenic Role of Mutant IDH2 in Leukemia Initiation and Maintenance","volume":"14","author":"Kats","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exphem.2014.11.009_bib32","doi-asserted-by":"crossref","first-page":"e89560","DOI":"10.1371\/journal.pone.0089560","article-title":"Activating FLT3 Mutants Show Distinct Gain-of-Function Phenotypes In\u00a0Vitro and a Characteristic Signaling Pathway Profile Associated with Prognosis in Acute Myeloid Leukemia","volume":"9","author":"Janke","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2014.11.009_bib33","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood-2010-08-301416","article-title":"SOCS1 cooperates with FLT3-ITD in the development of myeloproliferative disease by promoting the escape from external cytokine control","volume":"120","author":"Reddy","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.11.009_bib34","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood-2007-01-068809","article-title":"Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders","volume":"110","author":"Joslin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.11.009_bib35","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood.V86.8.3173.3173","article-title":"The expression pattern of erythrocyte\/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia","volume":"86","author":"Shimamoto","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.11.009_bib36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.cell.2004.10.010","article-title":"JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells","volume":"119","author":"Passegue","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2014.11.009_bib37","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1182\/blood-2009-05-223115","article-title":"High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia","volume":"114","author":"Tang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2014.11.009_bib38","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/sj.onc.1208344","article-title":"Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotype","volume":"24","author":"Neben","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2014.11.009_bib39","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3390\/ijms15021927","article-title":"Elevated Th22 cells correlated with Th17 cells in peripheral blood of patients with acute myeloid leukemia","volume":"15","author":"Yu","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.exphem.2014.11.009_bib40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-0609.2008.01083.x","article-title":"Gene expression profiling of Polycomb, Hox and Meis genes in patients with acute myeloid leukaemia","volume":"81","author":"Grubach","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.exphem.2014.11.009_bib41","doi-asserted-by":"crossref","first-page":"7695","DOI":"10.1158\/0008-5472.CAN-07-0484","article-title":"Epidermal growth factor receptors with tyrosine kinase domain mutations exhibit reduced Cbl association, poor ubiquitylation, and down-regulation but are efficiently internalized","volume":"67","author":"Padron","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2014.11.009_bib42","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.1158\/0008-5472.CAN-06-1042","article-title":"Association with HSP90 inhibits Cbl-mediated down-regulation of mutant epidermal growth factor receptors","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2014.11.009_bib43","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1038\/sj.onc.1210522","article-title":"Oncogenic activation of the Met receptor tyrosine kinase fusion protein, Tpr-Met, involves exclusion from the endocytic degradative pathway","volume":"26","author":"Mak","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2014.11.009_bib44","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3324\/haematol.2008.001149","article-title":"The fusion proteins TEL-PDGFRbeta and FIP1L1-PDGFRalpha escape ubiquitination and degradation","volume":"94","author":"Toffalini","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2014.11.009_bib45","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1046\/j.1365-2141.2000.01831.x","article-title":"Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells","volume":"108","author":"Fenski","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2014.11.009_bib46","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.leu.2403268","article-title":"Murine marrow cellularity and the concept of stem cell competition: geographic and quantitative determinants in stem cell biology","volume":"18","author":"Colvin","year":"2004","journal-title":"Leukemia"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X14008108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X14008108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:32:10Z","timestamp":1759566730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X14008108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0301472X14008108"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2014.11.009","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of c-Cbl E3 ubiquitin ligase activity enhances the development of myeloid leukemia in FLT3-ITD mutant mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2014.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}